Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures
- 27 March 2003
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 972 (1-2) , 119-126
- https://doi.org/10.1016/s0006-8993(03)02511-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Tolerability and Pharmacokinetics of the Nitrone NXY-059 in Patients With Acute StrokeStroke, 2001
- Recovery of functional status after right hemisphere stroke: Relationship with unilateral neglectArchives of Physical Medicine and Rehabilitation, 2001
- Tolerability of the Low-Affinity, Use-Dependent NMDA Antagonist AR-R15896AR in Stroke PatientsStroke, 2001
- Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1999
- Drug development for stroke: importance of protecting cerebral white matterEuropean Journal of Pharmacology, 1999
- Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.Pharmacology & Therapeutics, 1998
- Chapter 9 Pharmacology of AMPA Antagonists and their Role in NeuroprotectionPublished by Elsevier ,1996
- The protective action of chlormethiazole against ischaemia‐induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activityBritish Journal of Pharmacology, 1995
- Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbilBritish Journal of Pharmacology, 1991
- Patterns of Neglect DissociationBehavioural Neurology, 1989